Literature DB >> 20142327

Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.

Nathalie Ortega1, Ke Wang, Napoleone Ferrara, Zena Werb, Thiennu H Vu.   

Abstract

Long bone development depends on endochondral bone formation, a complex process requiring exquisite balance between hypertrophic cartilage (HC) formation and its ossification. Dysregulation of this process may result in skeletal dysplasias and heterotopic ossification. Endochondral ossification requires the precise orchestration of HC vascularization, extracellular matrix remodeling, and the recruitment of osteoclasts and osteoblasts. Matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF) and osteoclasts have all been shown to regulate endochondral ossification, but how their function interrelates is not known. We have investigated the functional relationship among these regulators of endochondral ossification, demonstrating that they have complementary but non-overlapping functions. MMP-9, VEGF and osteoclast deficiency all cause impaired growth plate ossification resulting in the accumulation of HC. VEGF mRNA and protein expression are increased at the MMP-9-/- growth plate, and VEGF activity contributes to endochondral ossification since sequestration of VEGF by soluble receptors results in further inhibition of growth plate vascularization and ossification. However, VEGF bioavailability is still limited in MMP-9 deficiency, as exogenous VEGF is able to rescue the MMP-9-/- phenotype, demonstrating that MMP-9 may partially, but not fully, regulate VEGF bioavailability. The organization of the HC extracellular matrix at the MMP-9-/- growth plate is altered, supporting a role for MMP-9 in HC remodeling. Inhibition of VEGF impairs osteoclast recruitment, whereas MMP-9 deficiency leads to an accumulation of osteoclasts at the chondro-osseous junction. Growth plate ossification in osteoclast-deficient mice is impaired in the presence of normal MMP-9 expression, indicating that other osteoclastic functions are also necessary. Our data delineate the complementary interplay between MMP-9, VEGF and osteoclast function that is necessary for normal endochondral bone formation and provide a molecular framework for investigating the molecular defects contributing to disorders of endochondral bone formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142327      PMCID: PMC2869494          DOI: 10.1242/dmm.004226

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  52 in total

1.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

Review 2.  Molecular mechanisms of endochondral bone development.

Authors:  Sylvain Provot; Ernestina Schipani
Journal:  Biochem Biophys Res Commun       Date:  2005-03-18       Impact factor: 3.575

Review 3.  Cellular and molecular interactions regulating skeletogenesis.

Authors:  Céline Colnot
Journal:  J Cell Biochem       Date:  2005-07-01       Impact factor: 4.429

4.  Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation.

Authors:  Nathalie Ortega; Danielle J Behonick; Céline Colnot; Douglas N W Cooper; Zena Werb
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

5.  Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification.

Authors:  Masaki Inada; Yingmin Wang; Michael H Byrne; Mahboob U Rahman; Chisato Miyaura; Carlos López-Otín; Stephen M Krane
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

6.  Altered endochondral bone development in matrix metalloproteinase 13-deficient mice.

Authors:  Dominique Stickens; Danielle J Behonick; Nathalie Ortega; Babette Heyer; Bettina Hartenstein; Ying Yu; Amanda J Fosang; Marina Schorpp-Kistner; Peter Angel; Zena Werb
Journal:  Development       Date:  2004-12       Impact factor: 6.868

Review 7.  Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair.

Authors:  Elazar Zelzer; Bjorn R Olsen
Journal:  Curr Top Dev Biol       Date:  2005       Impact factor: 4.897

8.  A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects.

Authors:  Beyhan Tuysuz; Rebecca Mosig; Gürkan Altun; Selim Sancak; Marc J Glucksman; John A Martignetti
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

9.  Osteoblastic responses to TGF-beta during bone remodeling.

Authors:  A Erlebacher; E H Filvaroff; J Q Ye; R Derynck
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

10.  MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover.

Authors:  K Holmbeck; P Bianco; J Caterina; S Yamada; M Kromer; S A Kuznetsov; M Mankani; P G Robey; A R Poole; I Pidoux; J M Ward; H Birkedal-Hansen
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

View more
  39 in total

1.  Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex.

Authors:  Allison S Harney; Laura B Sole; Thomas J Meade
Journal:  J Biol Inorg Chem       Date:  2012-05-22       Impact factor: 3.358

2.  Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model.

Authors:  Katherine Biron-Pain; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2011-08-11       Impact factor: 9.261

Review 3.  Overview of biological mechanisms and applications of three murine models of bone repair: closed fracture with intramedullary fixation, distraction osteogenesis, and marrow ablation by reaming.

Authors:  Beth Bragdon; Kyle Lybrand; Louis Gerstenfeld
Journal:  Curr Protoc Mouse Biol       Date:  2015-03-02

4.  c-Raf promotes angiogenesis during normal growth plate maturation.

Authors:  Eva S Liu; Adalbert Raimann; Byongsoo Timothy Chae; Janaina S Martins; Manuela Baccarini; Marie B Demay
Journal:  Development       Date:  2015-12-10       Impact factor: 6.868

5.  The critical role of the epidermal growth factor receptor in endochondral ossification.

Authors:  Xianrong Zhang; Valerie A Siclari; Shenghui Lan; Ji Zhu; Eiki Koyama; Holly L Dupuis; Motomi Enomoto-Iwamoto; Frank Beier; Ling Qin
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

6.  Impaired vibration of auditory ossicles in osteopetrotic mice.

Authors:  Sho Kanzaki; Yasunari Takada; Shumpei Niida; Yoshihiro Takeda; Nobuyuki Udagawa; Kaoru Ogawa; Nobuhito Nango; Atsushi Momose; Koichi Matsuo
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

7.  Choline kinase beta is required for normal endochondral bone formation.

Authors:  Zhuo Li; Gengshu Wu; Roger B Sher; Zohreh Khavandgar; Martin Hermansson; Gregory A Cox; Michael R Doschak; Monzur Murshed; Frank Beier; Dennis E Vance
Journal:  Biochim Biophys Acta       Date:  2014-03-14

8.  Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.

Authors:  Sun H Peck; John W Tobias; Eileen M Shore; Neil R Malhotra; Mark E Haskins; Margret L Casal; Lachlan J Smith
Journal:  Bone       Date:  2019-08-20       Impact factor: 4.398

9.  Epidermal growth factor receptor (EGFR) signaling regulates epiphyseal cartilage development through β-catenin-dependent and -independent pathways.

Authors:  Xianrong Zhang; Ji Zhu; Yumei Li; Tiao Lin; Valerie A Siclari; Abhishek Chandra; Elena M Candela; Eiki Koyama; Motomi Enomoto-Iwamoto; Ling Qin
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

Review 10.  Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders.

Authors:  Rita Dreier
Journal:  Arthritis Res Ther       Date:  2010-09-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.